Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $88,546.35 -1.73%
Ethereum $3,083.20 -0.69%
BNB $882.28 -1.30%
Optimism $0.30 -4.08%
Arbitrum $0.20 -5.74%
Solana $130.01 -1.77%
Polygon $0.22 +2.77%
Cosmos $2.11 -3.24%
Avalanche $12.94 -3.03%

Bitcoin $88,546.35 -1.73%
Ethereum $3,083.20 -0.69%
BNB $882.28 -1.30%
Optimism $0.30 -4.08%
Arbitrum $0.20 -5.74%
Solana $130.01 -1.77%
Polygon $0.22 +2.77%
Cosmos $2.11 -3.24%
Avalanche $12.94 -3.03%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed